10x Genomics Stock In The News
| TXG Stock | USD 10.34 0.46 4.66% |
Our overall analysis of 10X Genomics' news coverage and content from conventional and social sources shows investors' bearish mood towards 10X Genomics. The specific impact of 10X Genomics news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of 10X Genomics' overall financial health and prospects. It also depends on the type and quality of a news publisher.
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using 10X Genomics headlines in addition to utilizing other, more conventional financial analysis modules. Check out 10X Genomics Backtesting and 10X Genomics Hype Analysis. For more detail on how to invest in 10X Stock please use our How to Invest in 10X Genomics guide.
10X |
10X Genomics Today Top News and Investor Outlook
10X Genomics Past News Timeline
Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide 10X and other traded companies coverage with news coverage. We help investors stay connected with 10X headlines for the 14th of March 2025 to make an informed investment decision based on correlating the impacts of news items on 10X Stock performance. Please note that trading solely based on the 10X Genomics hype is not for everyone as timely availability and quick action are needed to avoid losses.
10X Genomics stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the 10X earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about 10X Genomics that are available to investors today. That information is available publicly through 10X media outlets and privately through word of mouth or via 10X internal channels. However, regardless of the origin, that massive amount of 10X data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of 10X Genomics news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of 10X Genomics relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to 10X Genomics' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive 10X Genomics alpha.
10X Largest EPS Surprises
Earnings surprises can significantly impact 10X Genomics' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2025-02-13 | 2024-12-31 | -0.1067 | -0.1356 | -0.0289 | 27 | ||
2024-10-29 | 2024-09-30 | -0.34 | -0.3 | 0.04 | 11 | ||
2020-02-18 | 2019-12-31 | -0.11 | -0.07 | 0.04 | 36 | ||
2024-02-15 | 2023-12-31 | -0.36 | -0.41 | -0.05 | 13 | ||
2021-11-03 | 2021-09-30 | -0.2 | -0.15 | 0.05 | 25 | ||
2023-05-03 | 2023-03-31 | -0.37 | -0.44 | -0.07 | 18 |
10X Genomics Stock Latest Headlines
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to 10X Genomics Stock. Current markets are strongly bullish. About 93% of major world exchanges and indexes are currently up. See today's market update for more information.
11th of March 2025
2 Reasons to Sell TXG and 1 Stock to Buy Instead at finance.yahoo.com
3rd of March 2025
10x Genomics Inc Stock Price Down 3.41 percent on Mar 3 at gurufocus.com
28th of February 2025
Disposition of 7942 shares by Serge Saxonov of 10X Genomics at 10.6262 subject to Rule 16b... at thelincolnianonline.com
26th of February 2025
10x Genomics, Inc. Receives Consensus Recommendation of Hold from Analysts at thelincolnianonline.com
18th of February 2025
10x Genomics to Participate in the 45th Annual TD Cowen Health Care Conference at finance.yahoo.com
14th of February 2025
10x Genomics Downgraded by Leerink Partnrs to Hold at thelincolnianonline.com
13th of February 2025
Q4 2024 10X Genomics Inc Earnings Call Transcript at gurufocus.com
10th of February 2025
10x Genomics Inc Trading Down 15.3 percent on Feb 10 at gurufocus.com
16th of January 2025
10x Genomics Cash Flow from Financing 11.1 Mil - GuruFocus.com at news.google.com
10X Genomics Investors Sentiment
The influence of 10X Genomics' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in 10X. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to 10X Genomics' public news can be used to forecast risks associated with an investment in 10X. The trend in average sentiment can be used to explain how an investor holding 10X can time the market purely based on public headlines and social activities around 10X Genomics. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
10X Genomics' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for 10X Genomics' and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average 10X Genomics' news discussions. The higher the estimated score, the more favorable is the investor's outlook on 10X Genomics.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards 10X Genomics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, 10X Genomics' short interest history, or implied volatility extrapolated from 10X Genomics options trading.
Check out 10X Genomics Backtesting and 10X Genomics Hype Analysis. For more detail on how to invest in 10X Stock please use our How to Invest in 10X Genomics guide.You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of 10X Genomics. If investors know 10X will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about 10X Genomics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.52) | Revenue Per Share | Quarterly Revenue Growth (0.10) | Return On Assets | Return On Equity |
The market value of 10X Genomics is measured differently than its book value, which is the value of 10X that is recorded on the company's balance sheet. Investors also form their own opinion of 10X Genomics' value that differs from its market value or its book value, called intrinsic value, which is 10X Genomics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because 10X Genomics' market value can be influenced by many factors that don't directly affect 10X Genomics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between 10X Genomics' value and its price as these two are different measures arrived at by different means. Investors typically determine if 10X Genomics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, 10X Genomics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.